We found that elevated pulse pressure was the most sensitive metric, negatively associated with axonal degeneration, astrocytic activation, and AD pathobiology (NfL, GFAP, pTau181), while elevated systolic blood pressure associated with increasing pTau burden (pTau181). Here, GFAP is linked to Alzheimer disease.